Logo do repositório

Insulin treatment reverses the increase in atrogin-1 expression in atrophied skeletal muscles of diabetic rats with acute joint inflammation

dc.contributor.authorPinheiro-Dardis, Clara Maria [UNESP]
dc.contributor.authorGutierres, Vânia Ortega [UNESP]
dc.contributor.authorAssis, Renata Pires [UNESP]
dc.contributor.authorPeviani, Sabrina Messa
dc.contributor.authorDelfino, Gabriel Borges
dc.contributor.authorDurigan, João Luiz Quagliotti
dc.contributor.authorSalvini, Tania de Fátima
dc.contributor.authorBaviera, Amanda Martins [UNESP]
dc.contributor.authorBrunetti, Iguatemy Lourenço [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionUniversidade Federal de São Carlos (UFSCar)
dc.contributor.institutionUniversity of Brasilia
dc.date.accessioned2018-12-11T17:18:03Z
dc.date.available2018-12-11T17:18:03Z
dc.date.issued2018-02-14
dc.description.abstractBackground: The aim of this study was to evaluate the changes in biomarkers of skeletal muscle proteolysis (atrogin-1, muscle RING finger-1 protein [MuRF-1]) and inflammation (nuclear factor kappa-B) in skeletal muscles of rats under two catabolic conditions, diabetes mellitus (DM) and acute joint inflammation, and the effects of insulin therapy. Materials and methods: Male Wistar rats were divided into groups without diabetes – normal (N), saline (NS), or ι-carrageenan (NCa) injection into the tibiotarsal joint – and groups with diabetes – diabetes (D), plus insulin (DI), saline (DS), or ι-carrageenan (DCa) injection into the tibiotarsal joint, or ι-carrageenan injection and treatment with insulin (DCaI). Three days after ι-carrageenan injection (17 days after diabetes induction), tibialis anterior (TA) and soleus (SO) skeletal muscles were used for analysis. Results: DM alone caused a significant decrease in the mass of TA and SO muscles, even with low levels of atrogenes (atrogin-1, MuRF-1), which could be interpreted as an adaptive mechanism to spare muscle proteins under this catabolic condition. The loss of muscle mass was exacerbated when ι-carrageenan was administered in the joints of diabetic rats, in association with increased expression of atrogin-1, MuRF-1, and nuclear factor kappa-B. Treatment with insulin prevented the increase in atrogin-1 (TA, SO) and the loss of muscle mass (SO) in diabetic-carrageenan rats; in comparison with TA, SO muscle was more responsive to the anabolic actions of insulin. Conclusion: Acute joint inflammation overcame the adaptive mechanism in diabetic rats to prevent excessive loss of muscle mass, worsening the catabolic state. The treatment of diabetic-carrageenan rats with insulin prevented the loss of skeletal muscle mass mainly via atrogin-1 inhibition. Under the condition of DM and inflammation, muscles with the prevalence of slow-twitch, type 1 fibers were more responsive to insulin treatment, recovering the ability to grow.en
dc.description.affiliationSão Paulo State University (UNESP) School of Pharmaceutical Sciences Department of Clinical Analysis
dc.description.affiliationFederal University of São Carlos (UFSCar) Department of Physical Therapy
dc.description.affiliationPhysical Therapy Division University of Brasilia
dc.description.affiliationUnespSão Paulo State University (UNESP) School of Pharmaceutical Sciences Department of Clinical Analysis
dc.description.sponsorshipConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.description.sponsorshipIdFAPESP: 2010/00892–0
dc.format.extent275-286
dc.identifierhttp://dx.doi.org/10.2147/TCRM.S142948
dc.identifier.citationTherapeutics and Clinical Risk Management, v. 14, p. 275-286.
dc.identifier.doi10.2147/TCRM.S142948
dc.identifier.issn1178-203X
dc.identifier.issn1176-6336
dc.identifier.scopus2-s2.0-85042160892
dc.identifier.urihttp://hdl.handle.net/11449/175901
dc.language.isoeng
dc.relation.ispartofTherapeutics and Clinical Risk Management
dc.relation.ispartofsjr0,748
dc.rights.accessRightsAcesso restritopt
dc.sourceScopus
dc.subjectAtrogenes
dc.subjectCreatine kinase
dc.subjectDiabetes mellitus
dc.subjectInflammation
dc.subjectInsulin
dc.subjectMuscle proteolysis
dc.subjectNF-κB
dc.titleInsulin treatment reverses the increase in atrogin-1 expression in atrophied skeletal muscles of diabetic rats with acute joint inflammationen
dc.typeArtigopt
dspace.entity.typePublication
relation.isDepartmentOfPublicationa83d26d6-5383-42e4-bb3c-2678a6ddc144
relation.isDepartmentOfPublication.latestForDiscoverya83d26d6-5383-42e4-bb3c-2678a6ddc144
unesp.author.lattes3736475025187750[8]
unesp.author.orcid0000-0003-0987-5295[8]
unesp.departmentAnálises Clínicas - FCFpt

Arquivos